<- Go Home
Endo Pharmaceuticals Solutions Inc.
Endo Pharmaceuticals Solutions Inc. operates as a specialty pharmaceutical company that engages in the acquisition, development, and commercialization of products to treat conditions in urology, endocrinology, and oncology. It develops Aveed, a testosterone undecanoate intramuscular injection. Endo Pharmaceuticals Solutions Inc. was formerly known as Indevus Pharmaceuticals, Inc. and changed its name to Endo Pharmaceuticals Solutions Inc. in March 2009. The company was founded in 1988 and is based in Lexington, Massachusetts. Endo Pharmaceuticals Solutions Inc. operates as a subsidiary of Branded Operations Holdings, Inc.
Market Cap
$440.6M
Volume
1.2M
Cash and Equivalents
$125.6M
EBITDA
-$39.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$56.3M
Profit Margin
64.10%
52 Week High
$6.15
52 Week Low
$1.19
Dividend
N/A
Price / Book Value
-3.22
Price / Earnings
-7.37
Price / Tangible Book Value
-2.04
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$43.9M
Return on Equity
52.61%
Return on Assets
-12.07
Cash and Short Term Investments
$125.6M
Debt
$175.7M
Equity
-$135.9M
Revenue
$87.8M
Unlevered FCF
-$15.4M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium